Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001801385-25-000002

Chief Accounting Officer sold 750 shares at $175.22 ($131,415)

  • Chief Accounting Officer gave up 8,054 shares (to pay taxes)
  • Chief Accounting Officer acquired 12,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROMANO KATHRYN · Chief Accounting Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-26 Shares withheld for taxes : show line 1 in the form 10b5-1 −2,268 $176.39 $400,053 13,354 D
2025-02-27 Sale : show line 2 in the form 10b5-1 −750 $175.22 $131,415 12,604 D
2025-02-28 Exercise or conversion : show line 3 in the form 10b5-1 +5,000 17,604 D
2025-02-28 Shares withheld for taxes : show line 4 in the form 10b5-1 −2,315 $179.25 $414,964 15,289 D
2025-02-28 Exercise or conversion : show line 5 in the form 10b5-1 +7,500 22,789 D
2025-02-28 Shares withheld for taxes : show line 6 in the form 10b5-1 −3,471 $179.25 $622,177 19,318 D
Open-market sales · 750 sh · avg $175.22 · $131,415

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-02-28 Exercise or conversion : show line 7 in the form 10b5-1 Performance Stock Units −5,000 0 D
2025-02-28 Exercise or conversion : show line 8 in the form 10b5-1 Performance Stock Units −7,500 7,500 D
2025-02-28 Grant or award : show line 9 in the form 10b5-1 Stock Option (Right to Buy) +10,000 10,000 D
2025-02-28 Grant or award : show line 10 in the form 10b5-1 Restricted Stock Units +2,200 2,200 D
Loading xslF345X05/wk-form4_1740787298.xml…